MSPEA takes Chinese drug company private
Morgan Stanley’s Asian private equity arm is investing alongside management to delist Singapore-listed Sihuan Pharmaceutical and will hold 15% of the company post-completion.
Morgan Stanley’s Asian private equity arm is investing alongside management to delist Singapore-listed Sihuan Pharmaceutical and will hold 15% of the company post-completion.
Copyright PEI Media
Not for publication, email or dissemination